All Pathways
NeurosurgeryManagement

Brain Abscess - Diagnosis and Management (ESCMID 2024)

Brain Abscess - Diagnosis and Management (ESCMID 2024): Suspected brain abscess (adult or child) → Assess symptoms and risk factors → Brain MRI with DWI...

Pathway Overview

20 steps

Algorithm Steps

20 total

  1. 01Start

    Suspected brain abscess (adult or child)

    Focal brain lesion with suspected infection. Treat as an emergency: involve neurosurgery and infectious diseases (ID) early.

  2. 02Action

    Assess symptoms and risk factors

    Headache is the most common symptom. Fever and focal deficit are often absent, so their absence does not rule out abscess.

    • Headache, fever, focal neurological deficit
    • Reduced consciousness, seizures, vomiting or papilloedema (raised ICP)
    • Risk factors: dental, sinus or ear infection; recent neurosurgery or head trauma
    • Risk factors: immunocompromise, HIV, endocarditis, congenital cyanotic heart disease, pulmonary AVM
  3. 03Action

    Brain MRI with DWI/ADC and gadolinium

    MRI is the test of choice (ESCMID strong, high). If MRI is not available, use contrast-enhanced CT.

    • Abscess: ring enhancement with restricted diffusion in the cavity (high DWI, low ADC)
    • Look for mass effect, hydrocephalus and rupture into the ventricles
    • Look for a local source: sinuses, mastoids, dentition
  4. 04Warning

    Ring-enhancing lesion: may not be a pyogenic abscess

    MRI is wrong in about 1 in 10 cases. Aspiration or excision gives the diagnosis.

    • Tumour or lymphoma can look the same
    • HIV with positive toxoplasma serology: treat toxoplasmosis first; aspiration usually not needed (ID advice)
    • HIV with negative toxoplasma serology: rule out CNS lymphoma
  5. 05Action

    First steps: blood cultures, referrals, no lumbar puncture

    Do not do a lumbar puncture: it is relatively contraindicated and the yield is low.

    • Blood cultures in all patients, before antibiotics
    • Urgent neurosurgery and ID referral
    • HIV test in all non-traumatic brain abscess
    • Before surgery: platelets, coagulation, and any anticoagulant or antiplatelet drug
  6. 06Action

    Empiric antibiotic regimen (adult and child doses)

    When to start depends on severity (next steps). Adjust doses for renal function. On valproate: carbapenems (meropenem, imipenem) lower valproate levels fast and can cause seizures; ask neurology or pharmacy. Severe beta-lactam allergy, pregnancy or age under 1 month: ask ID, but never delay antibiotics in severe disease.

    • Adult community-acquired: ceftriaxone 2 g IV 12-hourly (or cefotaxime 3 g IV 6-hourly) + metronidazole 500 mg IV 8-hourly
    • Child (1 month or older, under 50 kg), community-acquired: ceftriaxone 50 mg/kg IV 12-hourly (max 2 g/dose) + metronidazole 12.5 mg/kg IV 8-hourly (max 500 mg/dose)
    • Adult post-neurosurgical: meropenem 2 g IV 8-hourly + vancomycin (dose by weight and levels) or linezolid 600 mg IV 12-hourly
    • Severe immunocompromise (transplant, haematological cancer, active chemotherapy or biologics): community regimen + voriconazole + TMP-SMX; doses with ID
    • Pseudomonas risk (chronic suppurative otitis media): consider ceftazidime 2 g IV 8-hourly in place of ceftriaxone
    • Linezolid: check blood counts; beware serotonergic drugs
  7. 07Decision

    Severe disease? (sepsis, rupture or imminent rupture, signs of herniation)

    Severity decides whether antibiotics can wait for aspiration.

  8. If Yes
    1. Severe
    2. 08Warning

      Severe: start antibiotics now; do not wait for surgery

      Sepsis, ventricular rupture or imminent rupture, or impending herniation. Steroids before biopsy can mask CNS lymphoma: tell neurosurgery, but still give dexamethasone for impending herniation.

      • Blood cultures, then empiric antibiotics at once
      • Severe oedema or impending herniation: add dexamethasone (ESCMID strong)
      • Ventricular rupture or hydrocephalus: urgent neurosurgery; external ventricular drain often needed
    3. 09Action

      Severe: urgent aspiration or excision

      As soon as possible, with antibiotics already running. Correct coagulation first where possible.

      • Stereotactic aspiration for most abscesses
      • Excision: superficial non-eloquent or posterior fossa abscess, fungi, Nocardia
      • Not for toxoplasmosis in HIV
    4. 10Action

      Send pus from aspiration or excision

      Aerobic and anaerobic culture and histopathology in all.

      • Gram stain, aerobic and anaerobic culture
      • Histopathology
      • TB (Ziehl-Neelsen, culture, PCR), fungi or Nocardia if risk or endemic exposure
      • Store a sample for later molecular tests
    5. 11Action

      Find and treat the source

      Do not delay surgery or antibiotics for this.

      • Dental or ENT source, or oral cavity bacteria: ENT or maxillofacial review
      • Source unclear: chest X-ray or CT chest-abdomen-pelvis
      • TOE if bacteraemia with streptococci or S. aureus alone and no other cause
      • Recurrent abscess without cause: look for pulmonary AVM (CT pulmonary angiogram)
    6. 12Decision

      Pathogen identified?

      From pus or blood culture.

    7. If Yes
      1. 13Action

        Pathogen found: targeted therapy by susceptibility

        ESCMID strong. Doses as per local guideline and ID advice. On valproate: avoid carbapenems (meropenem, imipenem) where possible; they lower valproate levels fast.

        • Streptococci: benzylpenicillin or a 3rd-generation cephalosporin; oral cavity bacteria: keep anaerobic cover (metronidazole)
        • S. aureus: MSSA flucloxacillin; MRSA vancomycin or linezolid
        • Enterobacterales: 3rd-generation cephalosporin if susceptible, meropenem if resistant; Pseudomonas: ceftazidime + ciprofloxacin
        • Listeria: ampicillin; Nocardia: TMP-SMX + imipenem (ID advice)
        • Toxoplasma, fungi, TB: disease-specific treatment with ID
      2. 14Action

        Duration of IV antibiotics

        Aspirated or no surgery: 6 to 8 weeks IV. Excised: about 4 weeks IV may be enough (expert opinion).

        • Early switch to oral: no ESCMID recommendation (too little evidence); ID decision only
        • No routine oral consolidation after 6 weeks IV
        • Nocardia, TB, toxoplasma, fungi: disease-specific (often longer) courses
        • Do not extend antibiotics only for residual enhancement (can last 3 to 6 months)
      3. 15Action

        Monitoring and follow-up

        Image at once if the patient deteriorates. Otherwise image about every 2 weeks until clinical cure.

        • Re-aspirate or excise if worse or larger; almost always needed if no smaller by 4 weeks
        • Size often unchanged at 2 weeks after aspiration
        • Seizures: treat as epilepsy; no primary antiepileptic prophylaxis; avoid valproate with a carbapenem
        • Long IV course: blood count, renal and liver function about weekly; watch for metronidazole neuropathy, and for linezolid myelosuppression and optic neuritis
        • Refer for neurorehabilitation if deficits
      4. 16Outcome

        Cure, re-intervention or rehabilitation

        Mortality about 7% at 30 days and 20% at 1 year; sequelae are common. Dental antibiotic prophylaxis only if a right-to-left shunt remains.

      If No
      1. 17Action

        No pathogen: continue empiric regimen

        Ask for molecular tests (e.g. 16S rRNA PCR) on the pus if cultures are negative (ESCMID conditional).

      2. Path rejoins step 14Shared downstream outcome
    If No
    1. Not severe
    2. 18Decision

      Not severe: aspiration or excision possible within 24 h?

      ESCMID recommends aspiration or excision whenever feasible (strong).

    3. If Yes
      1. Within 24 h
      2. 19Action

        Not severe, surgery within 24 h: hold antibiotics until aspiration

        Holding antibiotics raises the culture yield (ESCMID conditional, low). Start antibiotics at once if the patient worsens or surgery is delayed. Already on antibiotics: do not stop them.

        • Blood cultures now
        • Start empiric antibiotics straight after pus is taken
        • Stereotactic aspiration for most; excision in selected cases
      3. Path rejoins step 10Shared downstream outcome
      If No
      1. Not within 24 h
      2. 20Action

        Not severe, surgery not possible within 24 h: start antibiotics now

        Blood cultures first. Arrange aspiration or excision as soon as feasible.

        • No surgery only if not feasible (e.g. small or deep abscess, or pathogen already known): neurosurgery and ID decision
        • Safety of no surgery is unclear; a tumour can be missed. Repeat imaging closely
        • Aspirate if the patient worsens or the abscess grows
      3. Path rejoins step 10Shared downstream outcome

Guideline Source

ESCMID guidelines on diagnosis and treatment of brain abscess in children and adults (Bodilsen et al., Clin Microbiol Infect 2024;30:66-89)

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Child doses given only for the community regimen (1 month or older, under 50 kg); neonates and other regimens need paediatric ID advice
  • Toxoplasmosis, Nocardia, TB and fungal abscess need disease-specific ID-led treatment not detailed here
  • Subdural empyema and epidural abscess are not covered
  • Follow local antibiotic guidelines and resistance patterns (in Australia, Therapeutic Guidelines)

Contraindicated Populations

Severely immunocompromised patients: regimen needs ID inputNeonates (under 1 month): doses not given

Applicable Regions

AUEUGlobal

AU: Nafcillin and oxacillin are not on the ARTG; flucloxacillin is the anti-staphylococcal penicillin. Check local dosing (Therapeutic Guidelines: Antibiotic).

EU: ESCMID 2024 guideline is the European standard.

Version 2Next review: 2027-09-30

Frequently Asked Questions

What is the Brain Abscess - Diagnosis and Management (ESCMID 2024)?

The Brain Abscess - Diagnosis and Management (ESCMID 2024) is a management clinical algorithm for Neurosurgery. It provides a structured decision tree to guide clinical decision-making, based on ESCMID guidelines on diagnosis and treatment of brain abscess in children and adults (Bodilsen et al., Clin Microbiol Infect 2024;30:66-89).

What guideline is the Brain Abscess - Diagnosis and Management (ESCMID 2024) based on?

This algorithm is based on ESCMID guidelines on diagnosis and treatment of brain abscess in children and adults (Bodilsen et al., Clin Microbiol Infect 2024;30:66-89) (DOI: 10.1016/j.cmi.2023.08.016).

What are the limitations of the Brain Abscess - Diagnosis and Management (ESCMID 2024)?

Known limitations include: Child doses given only for the community regimen (1 month or older, under 50 kg); neonates and other regimens need paediatric ID advice; Toxoplasmosis, Nocardia, TB and fungal abscess need disease-specific ID-led treatment not detailed here; Subdural empyema and epidural abscess are not covered; Follow local antibiotic guidelines and resistance patterns (in Australia, Therapeutic Guidelines). Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Brain Abscess - Diagnosis and Management (ESCMID 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free